follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Protalex completes $2.8M private placement

By

Back to Top Comments Print

Latest News

advertisement

Florham Park-based biopharmaceutical company Protalex announced Thursday it has completed a private placement financing in the amount of $2.82 million.

According to the announcement, the placement accredited investors in the form of 471,334 shares of common stock at $6 per share. Proceeds of the financing will be used for working capital purposes, principally to fund ongoing clinical trials and studies and related activities.


Like NJBIZ on Facebook: facebook.com/NJBIZ

Stay informed with free NJBIZ email newsletters >

Write to the Editorial Department at editorial@njbiz.com

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top